# Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

> **NCT00530868** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 75 (actual)

## Conditions studied

- Breast Cancer
- Cancer of the Breast
- Breast Neoplasm

## Interventions

- **OTHER:** Letrozole (Femara)
- **DRUG:** Letrozole; Avastin

## Key facts

- **NCT ID:** NCT00530868
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-08
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-31
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-10-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530868, "Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00530868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*